The novel compound STK405759 is a microtubule-targeting agent with potent and selective cytotoxicity against multiple myeloma in vitro and in vivo. (Q41825014)
Jump to navigation
Jump to search
scientific article published on 23 August 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The novel compound STK405759 is a microtubule-targeting agent with potent and selective cytotoxicity against multiple myeloma in vitro and in vivo. |
scientific article published on 23 August 2016 |
Statements
The novel compound STK405759 is a microtubule-targeting agent with potent and selective cytotoxicity against multiple myeloma in vitro and in vivo (English)
Gabriela Rozic
Lena Paukov
Jana Jakubikova
Adrian Duek
Adi Leiba
Abraham Avigdor
Arnon Nagler
1 September 2016
1 reference
1 reference
1 reference
1 reference